Publications by authors named "T Soysal"
Introduction: Therapeutic plasma exchange (TPE) may involve complications. We aimed to review the demographic data, indications, technical information, and complications.
Methods: Data for TPE procedures (TPEPs) performed between 2004 and 2018 were retrospectively.
Introduction: The advent of tyrosine kinase inhibitors (TKIs) was revolutionary in the management of chronic myeloid leukemia (CML). Although TKIs were generally considered to be safe, they can be associated with renal injury. We evaluated the effect of TKIs on renal functions in a cohort of patients with long-term follow-up.
View Article and Find Full Text PDFArticle Synopsis
- The study focuses on the 13q14.3 deletion, a common genetic abnormality in Chronic Lymphocytic Leukemia (CLL), and its relationship with tumor suppressor miRNAs, specifically hsa-miR-15a and hsa-miR-16-1.
- The research involved karyotyping and iFISH analysis of blood samples from 30 CLL patients, revealing that while only 8.6% showed 13q14.3 deletion via karyotyping, 65% had it detected by iFISH, indicating a higher sensitivity of the latter method.
- Results suggested that decreased levels of hsa-miR-16-1 correlate significantly with these deletions, and the use of DSP
Background: Cytogenetic findings are important prognostic factors in acute myeloid leukemia. Large systematic data about chromosomal characteristics of Turkish AML patients have not been reported to date.
Objectives: The karyotypic profiles of 157 adult AML patients were evaluated retrospectively and compared with other reports from different populations.
Objective: Redditux (RED), as a biosimilar rituximab, was approved in Turkey for all indications of the original Mabthera (MAB) in March 2018. The aim of our study was to evaluate the efficacy and safety of RED in de novo diffuse large B-cell lymphoma.
Materials And Methods: Fifty-one patients received RED combined with the CHOP regimen.